Cell Surface Markers Market by Product (Antibodies, PCR Arrays), Source (Mice, Rats), Cell Type, Application, End-User - Global Forecast 2024-2030

Cell Surface Markers Market by Product (Antibodies, PCR Arrays), Source (Mice, Rats), Cell Type, Application, End-User - Global Forecast 2024-2030


The Cell Surface Markers Market size was estimated at USD 785.86 million in 2023 and expected to reach USD 858.27 million in 2024, at a CAGR 9.30% to reach USD 1,465.18 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Surface Markers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Surface Markers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Surface Markers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., arigo Biolaboratories Corp., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., Creative Bioarray, Creative Diagnostics, Danaher Corporation, F. Hoffmann-La Roche Ltd., GenScript Biotech Corporation, Grifols SA, Merck KGaA, Nihon Kohden Corporation, PerkinElmer Inc., Qiagen N.V., Qima Ltd., R&D Systems, Inc., ScienCell Research Laboratories, Inc., Siemens Healthineers AG, Stemcell Technologies Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage


This research report categorizes the Cell Surface Markers Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Antibodies
PCR Arrays
Source
Mice
Rats
Cell Type
B Cell Surface Markers
Monocyte Cell Surface Markers
NK Cell Surface Markers
T Cell Surface Markers
Application
Clinical
Immunodeficiency Diseases

Oncology
Research
Drug Discovery

Immunology

Stem Cell Research
End-User
Academic & Research Institutes
Hospitals & Clinical Testing Laboratories
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Surface Markers Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Surface Markers Market?
3. What are the technology trends and regulatory frameworks in the Cell Surface Markers Market?
4. What is the market share of the leading vendors in the Cell Surface Markers Market?
5. Which modes and strategic moves are suitable for entering the Cell Surface Markers Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cell Surface Markers Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries
5.1.1.2. Rising need for adoption of in vitro diagnostics
5.1.1.3. Growing occurrence rate of cancer and other autoimmune diseases
5.1.2. Restraints
5.1.2.1. High costs associated with cell research activities
5.1.3. Opportunities
5.1.3.1. Growing investment in research and development to launch new drugs
5.1.3.2. Rising technological advancement in the healthcare sector
5.1.4. Challenges
5.1.4.1. Complexities associated with instruments and stringent regulatory compliances
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cell Surface Markers Market, by Product
6.1. Introduction
6.2. Antibodies
6.3. PCR Arrays
7. Cell Surface Markers Market, by Source
7.1. Introduction
7.2. Mice
7.3. Rats
8. Cell Surface Markers Market, by Cell Type
8.1. Introduction
8.2. B Cell Surface Markers
8.3. Monocyte Cell Surface Markers
8.4. NK Cell Surface Markers
8.5. T Cell Surface Markers
9. Cell Surface Markers Market, by Application
9.1. Introduction
9.2. Clinical
9.3.1. Immunodeficiency Diseases
9.3.2. Oncology
9.3. Research
9.4.1. Drug Discovery
9.4.2. Immunology
9.4.3. Stem Cell Research
10. Cell Surface Markers Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals & Clinical Testing Laboratories
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Cell Surface Markers Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cell Surface Markers Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Cell Surface Markers Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Abcam PLC
15.1.3. Agilent Technologies, Inc.
15.1.4. arigo Biolaboratories Corp.
15.1.5. Becton, Dickinson and Company
15.1.6. Bio-Rad Laboratories, Inc.
15.1.7. Bio-Techne Corporation
15.1.8. Cell Signaling Technology Inc.
15.1.9. Creative Bioarray
15.1.10. Creative Diagnostics
15.1.11. Danaher Corporation
15.1.12. F. Hoffmann-La Roche Ltd.
15.1.13. GenScript Biotech Corporation
15.1.14. Grifols SA
15.1.15. Merck KGaA
15.1.16. Nihon Kohden Corporation
15.1.17. PerkinElmer Inc.
15.1.18. Qiagen N.V.
15.1.19. Qima Ltd.
15.1.20. R&D Systems, Inc.
15.1.21. ScienCell Research Laboratories, Inc.
15.1.22. Siemens Healthineers AG
15.1.23. Stemcell Technologies Inc.
15.1.24. Sysmex Corporation
15.1.25. Thermo Fisher Scientific Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. CELL SURFACE MARKERS MARKET RESEARCH PROCESS
FIGURE 2. CELL SURFACE MARKERS MARKET SIZE, 2023 VS 2030
FIGURE 3. CELL SURFACE MARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL SURFACE MARKERS MARKET DYNAMICS
FIGURE 7. CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 12. CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CELL SURFACE MARKERS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. CELL SURFACE MARKERS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings